JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2006;59:1151-1159; doi:10.1136/jcp.2005.031195
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Love, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Love, S

MY APPROACH

Demyelinating diseases

S Love

Correspondence to:
S Love
Department of Neuropathology, University of Bristol Institute of Clinical Neurosciences, Frenchay Hospital, Bristol BS16 1LE, UK;seth.love{at}bris.ac.uk
ABSTRACT
A diagnosis of demyelination carries important therapeutic and prognostic implications. In most cases the diagnosis is made clinically, and involvement of the histopathologist is largely confined to postmortem confirmation and clinicopathological correlation. However, every now and then, accurate diagnosis of the presence or cause of demyelination before death hinges on the histopathological assessment. Recognition of demyelination depends on an awareness of this as a diagnostic possibility, and on the use of appropriate tinctorial and immunohistochemical stains to identify myelin, axons and inflammatory cells. In biopsy specimens, the critical distinction is usually from ischaemic or neoplastic disease, and the types of demyelinating disease most likely to be encountered are multiple sclerosis, acute-disseminated encephalomyelitis, progressive multifocal leucoencephalopathy and extrapontine myelinolysis. Interpretation of the pathology has to be made in the context of the clinical, radiological and biochemical findings. Freezing of a small amount of fresh tissue allows for later virological studies, and electron microscopy is occasionally helpful for demonstration of viral particles.


Abbreviations: ADEM, acute-disseminated encephalomyelitis; AHL, acute haemorrhagic leucoencephalitis; CNS, central nervous system; CPM, central pontine myelinolysis; CSF, cerebrospinal fluid; EPM, extrapontine myelinolysis; MRI, magnetic resonance imaging; PCR, polymerase chain reaction; PML, progressive multifocal leucoencephalopathy




This article has been cited by other articles:


Home page
NeurologyHome page
N. M. Moll, A. M. Rietsch, A. J. Ransohoff, M. B. Cossoy, D. Huang, F. S. Eichler, B. D. Trapp, and R. M. Ransohoff
Cortical demyelination in PML and MS: Similarities and differences
Neurology, January 29, 2008; 70(5): 336 - 343.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.